Su1451 - Regional Anesthesia in Laparoscopic Cholecystectomy. Experience in Southeast Mexico
2018; Elsevier BV; Volume: 154; Issue: 6 Linguagem: Inglês
10.1016/s0016-5085(18)34293-8
ISSN1528-0012
AutoresMercedes Amieva‐Balmori, Federico B. Roesch Dietlen, Julio Roberto Ballinas-Bustamante, Alfonso Gerardo Pérez-Morales, Jaime Anastasio Gómez-Delgado, Sylvia Martínez-Fernández, Yolopsi de Jesús Sanchez-Maza, F. Díaz-Roesch, José M. Remes Troche,
Tópico(s)Pancreatic and Hepatic Oncology Research
Resumoobservation times (Table 1).Overall survival (OS) was similar for all operations (p=0.79 for total pancreatectomy v non-total pancreatectomy), with 5-year OS (95% CI) of 80% (77-88%) for total pancreatectomy, 84% (77-88%) for distal pancreatectomy and 81% (77-84%) for pancreaticoduodenectomy.There were no statistically significant differences between operations comparing 30-day readmission, 30-day mortality and 90-day mortality.Positive margin status on final pathology was associated with worse overall survival HR (95% CI) = 1.63 (1.10-2.41)across all operations (Figure 1).Conclusion: Choice of operation does not change short or long-term outcomes following resection of non-invasive IPMN, but positive margin status is associated with worse survival.Converting a limited resection to a total pancreatectomy in the setting of positive intraoperative margins for IPMN should be considered.This study has the limitations inherent to a large retrospective database study, and the morbidity of endocrine and exocrine insufficiency must also be measured into this decision. Su1355
Referência(s)